Director and senior executive officer of Terumo Corporation and managing director of Terumo Asia Holdings, Hideo Arase recounts key takeaways from working in the US medtech market, the unique M&A opportunities he sees in Asia—especially as a pathway for bridging access to care in developing countries—while highlighting how Terumo can contribute to society beyond solely supplying a product.
Can you provide our readers with some insight on your background and how you came to oversee the group’s operations in Asia?
"[Asia-Pacific] is a region that is especially difficult from a compliance and governance perspective."
